A detailed history of State Street Corp transactions in Kempharm, Inc stock. As of the latest transaction made, State Street Corp holds 772,825 shares of KMPH stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
772,825
Previous 719,859 7.36%
Holding current value
$3.82 Million
Previous $3.56 Million 7.34%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
52,966 Added 7.36%
772,825 $3.82 Million
Q2 2024

Aug 14, 2024

BUY
N/A
36,687 Added 5.37%
719,859 $3.56 Million
Q1 2024

May 15, 2024

BUY
N/A
47,112 Added 7.41%
683,172 $3.37 Million
Q4 2023

Feb 14, 2024

BUY
N/A
7,833 Added 1.25%
636,060 $3.14 Million
Q3 2023

Nov 14, 2023

BUY
N/A
33,814 Added 5.69%
628,227 $3.1 Million
Q2 2023

Aug 14, 2023

BUY
$4.94 - $6.29 $2.39 Million - $3.05 Million
484,373 Added 440.18%
594,413 $2.94 Million
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $30,562 - $46,398
7,400 Added 7.21%
110,040 $605,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $5.21 $1.8 Million - $2.34 Million
-448,975 Reduced 81.39%
102,640 $458,000
Q1 2022

May 16, 2022

BUY
$5.0 - $9.26 $63,990 - $118,509
12,798 Added 2.38%
551,615 $2.78 Million
Q4 2021

Feb 14, 2022

SELL
$7.6 - $10.26 $58,763 - $79,330
-7,732 Reduced 1.41%
538,817 $4.69 Million
Q3 2021

Nov 15, 2021

BUY
$8.72 - $13.31 $459,901 - $701,982
52,741 Added 10.68%
546,549 $5.1 Million
Q2 2021

Aug 16, 2021

BUY
$8.52 - $15.47 $4.21 Million - $7.64 Million
493,808 New
493,808 $6.33 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.